Shmuel Ben-Sasson
Chief Technology Officer at Vitalunga, Senior Scientist at The Hebrew University of Jerusalem
Author of more than 90 scholarly articles in peer reviewed journals and the principal inventor of more than 20 granted patents. Among his significant scientific contributions is the invention and development of the TUNEL assay, now serving as the universal gold-standard for the in-situ identification of apoptosis.
Visit website: https://medicine.ekmd.huji.ac.il/en/research/mulib/Pages/default.aspx
See also: 
The Hebrew University of Jerusalem
- University in Jerusalem.
Details last updated 16-Aug-2022
Shmuel Ben-Sasson News
Mitophagy activators shown to increase lifespan and healthspan in C.elegans
Longevity Technology - 10-Aug-2022
Vitalunga to usher the novel drug for hepatocellular carcinoma clinical trials
Read more...
